World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
13440
World Ranking
3040
National Ranking
125

Hiroichi Nagai publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hiroichi Nagai sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 412 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hiroichi Nagai D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hiroichi Nagai sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hiroichi Nagai is affiliated with Gifu Pharmaceutical University in Japan. Their research profile does not include listed publications, co-authors, or specific topics of study available in the provided data. Similarly, there is no information on recent papers, main or subfields of study, or main topics related to their scientific work.

Details on publication venues or book publishers associated with Hiroichi Nagai are not documented. There are no recorded awards or honors attributed to this researcher in the available information.

Despite the limited data on their academic output, Hiroichi Nagai's position at Gifu Pharmaceutical University indicates involvement in pharmaceutical sciences or related disciplines within a higher education context in Japan.

Best Publications

  • Prostaglandin D2 as a Mediator of Allergic Asthma

    Toshiyuki Matsuoka;Masakazu Hirata;Hiroyuki Tanaka;Yoshimasa Takahashi

  • Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals

    Go Takayama;Kazuhiko Arima;Taisuke Kanaji;Shuji Toda

  • Involvement of Bruton's Tyrosine Kinase in FcεRI-dependent Mast Cell Degranulation and Cytokine Production

    Daisuke Hata;Yuko Kawakami;Naoki Inagaki;Chris S. Lantz

  • The Orally Available Spleen Tyrosine Kinase Inhibitor 2-[7-(3,4-Dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide Dihydrochloride (BAY 61-3606) Blocks Antigen-Induced Airway Inflammation in Rodents

    Noriyuki Yamamoto;Keisuke Takeshita;Michitaka Shichijo;Toshio Kokubo

  • Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia

    K. Hyakkoku;J. Hamanaka;K. Tsuruma;M. Shimazawa

  • Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3

    Tomonori Kunikata;Hana Yamane;Eri Segi;Toshiyuki Matsuoka

  • Synthesis and biological activities of novel antiallergic agents with 5-lipoxygenase inhibiting action.

    Hiroyuki Nakano;Tsutomu Inoue;Nobuhide Kawasaki;Hideki Miyataka

  • Inhibition of hypersensitivity reactions by a new drug, N(3',4'-dimethoxycinnamoyl) anthranilic acid (N-5').

    A. Koda;H. Nagai;S. Watanabe;Y. Yanagihara

  • Role of interleukin-5 and eosinophils in allergen-induced airway remodeling in mice.

    Hiroyuki Tanaka;Masato Komai;Koichi Nagao;Masayuki Ishizaki

  • Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity.

    Kenji Kabashima;Takahiko Murata;Hiroyuki Tanaka;Toshiyuki Matsuoka

  • An Essential Role of Mast Cells in the Development of Airway Hyperresponsiveness in a Murine Asthma Model

    Unknown

  • O-Methylated Catechins from Tea Leaves Inhibit Multiple Protein Kinases in Mast Cells

    Mari Maeda-Yamamoto;Naoki Inagaki;Jiro Kitaura;Takao Chikumoto

  • Effects of luteolin and other flavonoids on IgE-mediated allergic reactions.

    Masahiro Kimata;Naoki Inagaki;Hiroichi Nagai

  • Augmentation of allergic inflammation in prostanoid IP receptor deficient mice.

    Yoshimasa Takahashi;Shota Tokuoka;Taisei Masuda;Yousuke Hirano

  • Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcε receptor I cross-linking: an interspecies comparison

    Toshiharu Nakajima;Naoki Inagaki;Hiroyuki Tanaka;Akane Tanaka

  • Neuroprotection by Brazilian Green Propolis against In vitro and In vivo Ischemic Neuronal Damage.

    Masamitsu Shimazawa;Satomi Chikamatsu;Nobutaka Morimoto;Satoshi Mishima

  • Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage

    Nobutaka Morimoto;Masamitsu Shimazawa;Tetsumori Yamashima;Hiroichi Nagai

  • Methods of testing for bronchial asthma or chronic obstructive pulmonary disease

    Kenji Izuhara;Hiroshi Kubo;Hiroichi Nagai;Noriko Ohtani

  • Identification of Pendrin as a Common Mediator for Mucus Production in Bronchial Asthma and Chronic Obstructive Pulmonary Disease

    Isao Nakao;Sachiko Kanaji;Shoichiro Ohta;Hidetomo Matsushita

  • Lactobacillus Acidophilus Strain L-92 Regulates the Production of Th1 Cytokine as well as Th2 Cytokines

    Akiko Torii;Shinpei Torii;Shigeru Fujiwara;Hiroyuki Tanaka

  • Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80.

    Naoki Inagaki;Katsuhiro Igeta;John Fan Kim;Masafumi Nagao

Frequent Co-Authors

Naoki Inagaki
Naoki Inagaki Gifu Pharmaceutical University
Ikuo Saiki
Ikuo Saiki University of Toyama
Shuh Narumiya
Shuh Narumiya Kyoto University
Kenji Izuhara
Kenji Izuhara Saga Group
Hirohisa Saito
Hirohisa Saito Juntendo University
Kiyoshi Takatsu
Kiyoshi Takatsu University of Toyama
Koichi Shudo
Koichi Shudo University of Tokyo
Motohiro Ebisawa
Motohiro Ebisawa Juntendo University
Hideaki Hara
Hideaki Hara Gifu Pharmaceutical University
Munekazu Iinuma
Munekazu Iinuma Gifu Pharmaceutical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your healthcare expertise through related nursing and advanced practice roles can be highly beneficial. Many professionals consider transitioning their careers to roles like an Acute Care Nurse Practitioner (ACNP) to work closely with immunological conditions and critical care patients. If you're a Family Nurse Practitioner, learning how to transition from fnp to acnp can open new avenues in specialized care.

Getting started in nursing or advancing your credentials is easier with the availability of online programs. For instance, accelerated programs offer a faster pathway to becoming a nurse practitioner. Exploring the accelerated np program options online can help you achieve your goals without putting your life on hold.

Even if you don’t have a nursing background, you can transition into the field by starting with high-quality accredited online ADN programs. There are many choices specifically designed for those seeking online adn programs for non nurses, making the nursing pathway more accessible than ever.

If speed and accessibility are your main priorities, consider looking into the easiest accelerated nursing programs. These programs provide a fast-track route to earning your BSN, which serves as a foundation for advanced nursing careers closely aligned with immunology research and practice.

Best Scientists Citing Hiroichi Nagai

Recently Published Articles